NasdaqCM - Nasdaq Real Time Price USD

Belite Bio, Inc (BLTE)

Compare
59.42
+1.22
+(2.10%)
At close: January 24 at 4:00:01 PM EST
57.07
-2.35
(-3.95%)
Pre-Market: 4:32:57 AM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
35,494.00
31,668.00
12,821.00
9,797.00
5,743.00
Operating Income
-35,494.00
-31,668.00
-12,821.00
-9,797.00
-5,743.00
Net Non Operating Interest Income Expense
--
49.00
7.00
5.00
-9.00
Other Income Expense
2,416.00
-4.00
166.00
126.00
--
Pretax Income
-33,029.00
-31,623.00
-12,648.00
-9,666.00
-5,752.00
Tax Provision
5.00
9.00
--
--
1.00
Net Income Common Stockholders
-33,034.00
-31,632.00
-12,648.00
-9,666.00
-5,753.00
Diluted NI Available to Com Stockholders
-33,034.00
-31,632.00
-12,648.00
-9,666.00
-5,753.00
Basic EPS
-1.10
-1.19
-0.63
-0.40
-0.24
Diluted EPS
-1.10
-1.19
-0.63
-0.40
-0.24
Basic Average Shares
29,757.32
26,593.67
19,976.60
24,095.32
24,095.32
Diluted Average Shares
29,757.32
26,593.67
19,976.60
24,095.32
24,095.32
Total Operating Income as Reported
-35,494.00
-31,668.00
-12,821.00
-9,797.00
-5,743.00
Total Expenses
35,494.00
31,668.00
12,821.00
9,797.00
5,743.00
Net Income from Continuing & Discontinued Operation
-33,034.00
-31,632.00
-12,648.00
-9,666.00
-5,753.00
Normalized Income
-33,034.00
-31,632.00
-12,648.00
-9,666.00
-5,753.00
Interest Income
--
74.00
23.00
5.00
12.00
Interest Expense
--
25.00
16.00
--
21.00
Net Interest Income
--
49.00
7.00
5.00
-9.00
EBIT
-35,424.00
-31,598.00
-12,632.00
-9,666.00
-5,731.00
EBITDA
-35,424.00
-31,199.00
-12,434.00
-9,636.00
-5,714.00
Reconciled Depreciation
--
399.00
198.00
30.00
17.00
Net Income from Continuing Operation Net Minority Interest
-33,034.00
-31,632.00
-12,648.00
-9,666.00
-5,753.00
Normalized EBITDA
-35,424.00
-31,199.00
-12,434.00
-9,636.00
-5,714.00
Tax Rate for Calcs
0.00
0.00
--
--
0.00
12/31/2020 - 4/29/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6696.TWO Lin BioScience, Inc.
152.00
+4.47%
 
GYRE Gyre Therapeutics, Inc.
11.19
+5.57%
 
DNTH Dianthus Therapeutics, Inc.
21.21
-4.80%
 
CRGX CARGO Therapeutics, Inc.
13.46
-2.75%
 
CYCCP Cyclacel Pharmaceuticals, Inc.
8.50
+22.30%
 
PCVX Vaxcyte, Inc.
89.64
-0.37%
 
6564.TWO Enimmune corporation
26.15
0.00%
 
6945.TWO AP Biosciences Inc
50.90
+0.20%
 
COYA Coya Therapeutics, Inc.
5.90
-1.01%
 
ANAB AnaptysBio, Inc.
16.85
+1.32%